Abstract
Objectives: Breast cancer is the uncontrolled growth of breast cells. It is the second leading cause of cancer deaths in women worldwide. Thus, predicting the survivability of breast cancer is of great importance. The goal of this paper is to study the temporal effects of some features that describe breast cancer on the prediction of survivability.
Methods: In the present study, several artificial intelligence (AI)-based approaches are implemented for predicting the survivability of breast cancer based on the rate of change of variables in the patient’s record. These values are used as features that characterize each patient and are employed in the learning process instead of the original variables. Four prediction models are built and compared using a proposed set of features. The models include artificial neural networks (ANN), K-nearest neighbors (KNN), support vector machines (SVM), and logistic regression (LR). The approach is applied to a large publicly available dataset of breast cancers. For each model, performance measures when a model is built using the proposed features are compared against those obtained when the original values are used instead. Results: For all four models, improved prediction accuracy was obtained when the rate of change of variables rather than the raw values were used. ANN yielded the best prediction accuracy, sensitivity, and specificity. The LR model yielded the worst performance measures. Conclusion: The results of this study provide a foundation for future research on medical decision making, where the temporal effect of patients’ data should be taken into consideration when an AIbased system is used.Keywords: Breast cancer, survivability prediction, classification, SEER, cancer registry, death prediction, data mining.
Graphical Abstract
Current Bioinformatics
Title:On the Temporal Effects of Features on the Prediction of Breast Cancer Survivability
Volume: 12 Issue: 4
Author(s): Doaa M. Shawky*Ahmed F. Seddik
Affiliation:
- Engineering Mathematics Department, Faculty of Engineering, Cairo University, 12613 Giza,Egypt
Keywords: Breast cancer, survivability prediction, classification, SEER, cancer registry, death prediction, data mining.
Abstract: Objectives: Breast cancer is the uncontrolled growth of breast cells. It is the second leading cause of cancer deaths in women worldwide. Thus, predicting the survivability of breast cancer is of great importance. The goal of this paper is to study the temporal effects of some features that describe breast cancer on the prediction of survivability.
Methods: In the present study, several artificial intelligence (AI)-based approaches are implemented for predicting the survivability of breast cancer based on the rate of change of variables in the patient’s record. These values are used as features that characterize each patient and are employed in the learning process instead of the original variables. Four prediction models are built and compared using a proposed set of features. The models include artificial neural networks (ANN), K-nearest neighbors (KNN), support vector machines (SVM), and logistic regression (LR). The approach is applied to a large publicly available dataset of breast cancers. For each model, performance measures when a model is built using the proposed features are compared against those obtained when the original values are used instead. Results: For all four models, improved prediction accuracy was obtained when the rate of change of variables rather than the raw values were used. ANN yielded the best prediction accuracy, sensitivity, and specificity. The LR model yielded the worst performance measures. Conclusion: The results of this study provide a foundation for future research on medical decision making, where the temporal effect of patients’ data should be taken into consideration when an AIbased system is used.Export Options
About this article
Cite this article as:
Shawky M. Doaa*, Seddik F. Ahmed, On the Temporal Effects of Features on the Prediction of Breast Cancer Survivability, Current Bioinformatics 2017; 12 (4) . https://dx.doi.org/10.2174/1574893611666160511130633
DOI https://dx.doi.org/10.2174/1574893611666160511130633 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thromboprophylaxis in Medical Patients: An Update
Vascular Disease Prevention (Discontinued) Targeting of Cancer-Related Proteins with PNA Oligomers
Current Cancer Drug Targets Exocrine Pancreas Involvement in Celiac Disease: A Review
Recent Patents on Inflammation & Allergy Drug Discovery The Analysis of the Druggable Families Based on Topological Features in the Protein-Protein Interaction Network
Letters in Drug Design & Discovery Solid Lipid Nanoparticles: An Innovative Nano-Vehicles for Drug Delivery
Nanoscience & Nanotechnology-Asia Dietary and Lifestyle Factors and Breast Cancer Risk
Current Nutrition & Food Science Biologically Active Natural Products of the Genus Callicarpa
Current Bioactive Compounds Update on Evidence that Support a Role of Solar Ultraviolet-B Irradiance in Reducing Cancer Risk
Anti-Cancer Agents in Medicinal Chemistry Four Major Factors Regulate Phosphatidylinositol 3-kinase Signaling Pathway in Cancers Induced by Infection of Human Papillomaviruses
Current Medicinal Chemistry The Cellular Pharmacokinetics of HIV Protease Inhibitors: Current Knowledge and Future Perspectives
Current Drug Metabolism Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection
Mini-Reviews in Medicinal Chemistry Human Immunodeficiency Virus-Associated Malignancies: A Therapeutic Update
Current HIV Research Nanoliposomal Encapsulation Enhances In Vivo Anti-Tumor Activity of Niclosamide against Melanoma
Anti-Cancer Agents in Medicinal Chemistry Influence of Pulsing Electromagnetic Field Therapy on Gene Expression in Muscle Cells, Peripheral Circulation, and Metabolic Factors in Aging Adults
Current Chemical Biology Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer
Current Protein & Peptide Science Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines
Current Cancer Drug Targets Editorial (Thematic Issue: Elderly Cancer Patients in the 3rd Millenium: Between Hope and Reality. Introduction)
Anti-Cancer Agents in Medicinal Chemistry Bilirubin and the Genome: The Hereditary Basis of Unconjugated Neonatal Hyperbilirubinemia
Current Pharmacogenomics Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets
CNS & Neurological Disorders - Drug Targets Soy Protein Remnants Digested by Gastro-duodenal Proteases can Alter Microbial Interactions and Intestinal Cholesterol Absorption
Current Proteomics